Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor responder 2 pseudogene 11 (RARRES2P11) is a pseudogene in the human genome. Pseudogenes are nonfunctional DNA segments that resemble known genes but typically do not encode functional proteins; most arise from gene duplication or retrotransposition and subsequently accumulate disabling mutations[2][4][5]. While some pseudogenes may be transcribed or play minor regulatory roles via RNA-based mechanisms, RARRES2P11 is not known to have any functional or therapeutic relevance and is not considered a valid pharmacological target[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 11 (RARRES2P11).